Description

This study explores how newspapers framed the weight-loss drugs Xenical®(orlistat) and Alli® (over-the-counter orlistat) during the time period of three months prior to their approvals by the U.S. Food and Drug Administration until one year after each became available

This study explores how newspapers framed the weight-loss drugs Xenical®(orlistat) and Alli® (over-the-counter orlistat) during the time period of three months prior to their approvals by the U.S. Food and Drug Administration until one year after each became available on the market. As of June 2011, orlistat is the only weight-loss drug available for long-term use in the U.S.

Reuse Permissions
  • Downloads
    pdf (464.2 KB)

    Download count: 0

    Details

    Contributors
    Date Created
    2011
    Resource Type
  • Text
  • Collections this item is in
    Note
    • Partial requirement for: M.S., Arizona State University, 2011
      Note type
      thesis
    • Includes bibliographical references (p. 32-44)
      Note type
      bibliography
    • Field of study: Nutrition

    Citation and reuse

    Statement of Responsibility

    Jessica Lehmann

    Machine-readable links